Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 906948, 12 pages
http://dx.doi.org/10.1155/2013/906948
Research Article

An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model

1Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, University of Minnesota Medical School, Center for Infectious Diseases and Microbiology Translational Research, 2001 6th Street SE, Minneapolis, MN 55455, USA
2Food and Drug Administration, Regulatory Review Office, Rockville, MD 20852, USA
3Texas A & M Health Sciences Center, Microbial and Molecular Pathogenesis, College Station, TX 77843, USA
4Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, 717 Delaware Street SE, Minneapolis, MN 55455, USA

Received 4 February 2013; Revised 24 May 2013; Accepted 5 June 2013

Academic Editor: Philipp Henneke

Copyright © 2013 Michael P. Leviton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Nyholm and M. R. Schleiss, “Prevention of maternal cytomegalovirus infection: current status and future prospects,” International Journal of Women's Health, vol. 2, no. 1, pp. 23–35, 2010. View at Google Scholar · View at Scopus
  2. S. E. Oliver, G. A. Cloud, P. J. Sánchez et al., “Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system,” Journal of Clinical Virology, vol. 46, supplement 4, pp. S22–S26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Whitley, “Congenital cytomegalovirus infection: epidemiology and treatment,” Advances in Experimental Medicine and Biology, vol. 549, pp. 155–160, 2004. View at Google Scholar · View at Scopus
  4. E. C. Swanson and M. R. Schleiss, “Congenital cytomegalovirus infection: new prospects for prevention and therapy,” Pediatric Clinics of North America, vol. 60, no. 2, pp. 335–349, 2013. View at Google Scholar
  5. M. R. Schleiss, “Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns,” ILAR Journal, vol. 47, no. 1, pp. 65–72, 2006. View at Google Scholar · View at Scopus
  6. E. R. Kern, “Pivotal role of animal models in the development of new therapies for cytomegalovirus infections,” Antiviral Research, vol. 71, no. 2-3, pp. 164–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Miller-Kittrell and T. E. Sparer, “Feeling manipulated: cytomegalovirus immune manipulation,” Virology Journal, vol. 6, article 4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Hengel, W. Brune, and U. H. Koszinowski, “Immune evasion by cytomegalovirus—survival strategies of a highly adapted opportunist,” Trends in Microbiology, vol. 6, no. 5, pp. 190–197, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. E. S. Mocarski Jr., “Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion,” Trends in Microbiology, vol. 10, no. 7, pp. 332–339, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Mocarski Jr., “Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system,” Cellular Microbiology, vol. 6, no. 8, pp. 707–717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. F. Vischer, C. Vink, and M. J. Smit, “A viral conspiracy: hijacking the chemokine system through virally encoded pirated chemokine receptors,” Current Topics in Microbiology and Immunology, vol. 303, pp. 121–154, 2006. View at Google Scholar · View at Scopus
  12. C. Powers, V. DeFilippis, D. Malouli, and K. Früh, “Cytomegalovirus immune evasion,” Current Topics in Microbiology and Immunology, vol. 325, pp. 333–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Haggerty and M. R. Schleiss, “A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus,” Virus Genes, vol. 25, no. 3, pp. 271–279, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Penfold, Z. Miao, Y. Wang, S. Haggerty, and M. R. Schleiss, “A macrophage inflammatory protein homolog encoded by guinea pig cytomegalovirus signals via CC chemokine receptor 1,” Virology, vol. 316, no. 2, pp. 202–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Schraff, D. K. Brown, M. R. Schleiss, J. Meinzen-Derr, J. H. Greinwald, and D. I. Choo, “The role of CMV inflammatory genes in hearing loss,” Otology and Neurotology, vol. 28, no. 7, pp. 964–969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Schraff, M. R. Schleiss, D. K. Brown et al., “Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury,” Otolaryngology, vol. 137, no. 4, pp. 612–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. I. Bernstein, “Vaccines for cytomegalovirus,” Infectious Disorders Drug Targets, vol. 11, no. 5, pp. 514–525, 2011. View at Publisher · View at Google Scholar
  18. C. Söderberg-Nauclér, “Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?” Journal of Internal Medicine, vol. 259, no. 3, pp. 219–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Čičin-Šain, I. Bubić, M. Schnee et al., “Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy,” Journal of Virology, vol. 81, no. 24, pp. 13825–13834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Mohr, L. Cîcîn-Saîn, M. Wagner et al., “Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines,” International Journal of Medical Microbiology, vol. 298, no. 1-2, pp. 115–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Mohr, J. Arapovic, H. Mühlbach et al., “A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination,” Journal of Virology, vol. 84, no. 15, pp. 7730–7742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. P. Johnson, “Mouse cytomegalovirus: placental infection,” Journal of Infectious Diseases, vol. 120, no. 4, pp. 445–450, 1969. View at Google Scholar · View at Scopus
  23. A. McGregor and M. R. Schleiss, “Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli,” Molecular Genetics and Metabolism, vol. 72, no. 1, pp. 15–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. A. McGregor, F. Liu, and M. R. Schleiss, “Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone,” Virus Research, vol. 101, no. 2, pp. 101–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Saederup, S. A. Aguirre, T. E. Sparer, D. M. Bouley, and E. S. Mocarski, “Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection,” Journal of Virology, vol. 75, no. 20, pp. 9966–9976, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Crumpler, K. Y. Choi, M. A. McVoy, and M. R. Schleiss, “A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection,” Vaccine, vol. 27, no. 31, pp. 4209–4218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. Schleiss, “Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene,” Virology, vol. 202, no. 1, pp. 173–185, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. M. R. Schleiss, N. Bourne, F. J. Bravo, N. J. Jensen, and D. I. Bernstein, “Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection,” Journal of Virological Methods, vol. 108, no. 1, pp. 103–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. T. M. Muffly and M. D. Barber, “Insertion and removal of vaginal mesh for pelvic organ prolapse,” Clinical Obstetrics and Gynecology, vol. 53, no. 1, pp. 99–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Nozawa, Y. Yamamoto, Y. Fukui et al., “Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture,” Virology, vol. 379, no. 1, pp. 45–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. J. F. Kaptein, K. W. R. van Cleef, Y. K. Gruijthuijsen et al., “The r131 gene of rat cytomegalovirus encodes a proinflammatory CC chemokine homolog which is essential for the production of infectious virus in the salivary glands,” Virus Genes, vol. 29, no. 1, pp. 43–61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Schleiss, N. Bourne, G. Stroup, F. J. Bravo, N. J. Jensen, and D. I. Bernstein, “Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine,” Journal of Infectious Diseases, vol. 189, no. 8, pp. 1374–1381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Fleming, N. Davis-Poynter, M. Degli-Esposti et al., “The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity,” Journal of Virology, vol. 73, no. 8, pp. 6800–6809, 1999. View at Google Scholar · View at Scopus
  34. I. Slavuljica, A. Busche, M. Babić et al., “Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties,” Journal of Clinical Investigation, vol. 120, no. 12, pp. 4532–4545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Sung and M. R. Schleiss, “Update on the current status of cytomegalovirus vaccines,” Expert Review of Vaccines, vol. 9, no. 11, pp. 1303–1314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Yamada, N. Nozawa, H. Katano et al., “Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130,” Virology, vol. 391, no. 1, pp. 99–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. B. J. Ryckman, M. C. Chase, and D. C. Johnson, “HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 37, pp. 14118–14123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. B. J. Ryckman, M. A. Jarvis, D. D. Drummond, J. A. Nelson, and D. C. Johnson, “Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion,” Journal of Virology, vol. 80, no. 2, pp. 710–722, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. B. J. Ryckman, B. L. Rainish, M. C. Chase et al., “Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells,” Journal of Virology, vol. 82, no. 1, pp. 60–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Hahn, M. G. Revello, M. Patrone et al., “Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes,” Journal of Virology, vol. 78, no. 18, pp. 10023–10033, 2004. View at Google Scholar
  41. M. Auerbach, D. Yan, A. Fouts et al., “Characterization of the guinea pig CMV gH/gL/GP129/GP131/GP133 complex in infection and spread,” Virology, vol. 441, no. 1, pp. 75–84, 2013. View at Publisher · View at Google Scholar
  42. X. Cui, A. McGregor, M. R. Schleiss, and M. A. McVoy, “Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication,” Journal of Virological Methods, vol. 149, no. 2, pp. 231–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. S. G. Hansen, J. B. Sacha, C. M. Hughes et al., “Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms,” Science, vol. 340, no. 6135, pp. 1–17, 2013. View at Publisher · View at Google Scholar